Pro challenge
Sign in
Get 3 actionable money tips every week. Sign up for the tips now!
FBIOX vs IBB
FBIOX is a mutual fund, whereas IBB is an ETF. FBIOX has a higher 5-year return than IBB (5.85% vs 3.56%). FBIOX has a higher expense ratio than IBB (0.72% vs 0.47%). Below is the comparison between FBIOX and IBB.
| IBB | FBIOX | |
|---|---|---|
| Security Type | ETF | Mutual fund |
| Segment | Equity: U.S. Biotech | Specialty: Health |
| Issuer | BlackRock | Fidelity Investments |
| Net Assets | $7.66B | $7.08B |
| Expense Ratio | 0.47% | 0.72% |
| Management Style | passive (index-based) | active |
| Dividend Yield | 0.13% | 0.00% |
| Minimum Investment | N/A | $2,500.00 |
| YTD Return | 24.26% | 31.25% |
| 1-Year Return | 9.83% | 17.47% |
| 3-Year Return | 9.65% | 11.25% |
| 5-Year Return | 3.56% | 5.85% |
| 10-Year Return | 16.68% | 18.56% |
FBIOX description
The Fund seeks capital appreciation. Fidelity Management & Research normally invests in companies principally engaged in the research, development, and manufacture of various biotechnology products, services, and processes. They may also invest the assets in companies that distribute these products.
FBIOX returns
| YTD Return | 31.25% |
| 1-Month Return | 13.71% |
| 3-Month Return | 15.11% |
| 1-Year Return | 17.47% |
| 3-Year Return | 11.25% |
| 5-Year Return | 5.85% |
| 10-Year Return | 18.56% |
FBIOX expense ratio is 0.72%.
FBIOX holdings
Top 10 Holdings (39.37% of Total Assets)
| Name | Symbol | % Assets |
|---|---|---|
| AbbVie Inc | ABBV | 10.96% |
| Amgen Inc | AMGN | 7.04% |
| Vertex Pharmaceuticals Inc | VRTX | 4.84% |
| Gilead Sciences Inc | GILD | 3.82% |
| Alexion Pharmaceuticals Inc | ALXN | 2.65% |
| Neurocrine Biosciences Inc | NBIX | 2.27% |
| Alnylam Pharmaceuticals Inc | ALNY | 1.98% |
| Biogen Inc | BIIB | 1.98% |
| Sage Therapeutics Inc | SAGE | 1.96% |
| Ionis Pharmaceuticals Inc | IONS | 1.87% |
IBB description
The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Nasdaq Biotechnology Index (the "Index").
IBB returns
| YTD Return | 24.26% |
| 1-Month Return | 11.47% |
| 3-Month Return | 16.33% |
| 1-Year Return | 9.83% |
| 3-Year Return | 9.65% |
| 5-Year Return | 3.56% |
| 10-Year Return | 16.68% |
IBB expense ratio is 0.47%.
IBB holdings
Top 10 Holdings (54.15% of Total Assets)
| Name | Symbol | % Assets |
|---|---|---|
| Celgene Corp | CELG | 8.56% |
| Amgen Inc | AMGN | 7.84% |
| Gilead Sciences Inc | GILD | 7.69% |
| Vertex Pharmaceuticals Inc | VRTX | 6.7% |
| Illumina Inc | ILMN | 5.79% |
| Biogen Inc | BIIB | 5.22% |
| Regeneron Pharmaceuticals Inc | REGN | 4.05% |
| Alexion Pharmaceuticals Inc | ALXN | 3.27% |
| Seattle Genetics Inc | SGEN | 2.53% |
| Incyte Corp | INCY | 2.5% |
